Our primary objectives are to decode **signatures** of activity from the electrode that might prelude or accompany an OCD attack, by analyzing its activity in an experimental setting and in real-life situations, and to correlate symptom changes with…
ID
Source
Brief title
Condition
- Psychiatric and behavioural symptoms NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
1. DBS-related changes in amplitude, phase stability and frontostriatal
connectivity of theta (~4 Hz), alpha (~10 Hz) and gamma (>40 Hz) EEG
oscillations at electrode contacts and scalp
2. Amplitude, phase stability of theta, alpha and gamma EEG oscillations
measured at the electrodes that prelude and accompany the emergence of a
compulsive episode during real-life situations
3. DBS-related clinical changes on clinician-rated questionnaires:
- Yale Brown of Obsessive-Compulsive Scale (Goodman et al., 1989)
- Hamilton Scale for Depression (Hamilton, 1960)
- Hamilton Anxiety Scale (Hamilton, 1959)
- Symptom provocation during IAPS picture task (Bradley and Lang, 2007)
- Shortened 5-item obsessive-compulsive scale (VAS - visual analogue scale)
Secondary outcome
1. Characteristics of corticostriatal EEG oscillations that are associated with
various cognitive and behavioral paradigms and with sleep.
2. Written dairy of OCD symptom experiences and daily activities (for 1 day)
3. Demographic information not obtainable from clinical file (e.g. handedness)
Background summary
Deep Brain Stimulation (DBS) of the ventral part of the anterior internal
capsule (vALIC) is a promising option for patients with otherwise
treatment-refractory obsessive-compulsive Disorder (OCD) (Denys et al 2010).
However, the high variability among patients and clinical response patterns has
made it difficult to gain systematic insight into the optimal neurosurgical
target and stimulation settings. At present, stimulation parameters are based
on clinical feedback and previous experience with other patients, which is
time-consuming, inefficient and subjective. A quantitatively driven approach to
tailor stimulation parameters is urgently needed for more effective and
efficient clinical treatment. Preliminary work by our group indicates that
neural changes in the frontostriatal network are essential for efficacy of DBS.
Recently we acquired prototype bi-directional brain radio devices that not only
stimulate but also record activity from the targeted brain structure. We
propose to use these unique devices in select patients already implanted with
or eligible for DBS electrodes, in order to develop more effective and
systematic stimulation DBS parameters. Moreover, these devices will also afford
us the possibility to get a greater understanding of the neural pathophysiology
of OCD that can be targeted with DBS and other treatment modalities, by
allowing us to monitor the brain activity of patients as they experience
symptoms in daily life situations.
Study objective
Our primary objectives are to decode **signatures** of activity from the
electrode that might prelude or accompany an OCD attack, by analyzing its
activity in an experimental setting and in real-life situations, and to
correlate symptom changes with corticostriatal response at different settings
by recording local neural activity (EEG oscillatory amplitude) and network
activity (EEG oscillatory phase stability and frontostriatal connectivity) at
the electrodes and the scalp.
Our second objective is to investigate DBS induced changes in corticostriatal
EEG oscillations that are associated with various cognitive and behavioral
paradigms and with cortisol levels.
Study design
Observational cohort study in 11 OCD patients that are in need of battery
replacement or are eligible for a first DBS implantation. Instead of a regular
neurostimulator, these patients will receive a bi-directional brain radio
device. We will use this device to record DBS-related neural changes which will
be correlated with relevant clinical changes.
Study burden and risks
The benefit for participants of this study will be indirect, as the results of
this study will allow more efficient DBS for other OCD patients. Patients
eligible for the study are in need of a stimulator replacement or a new DBS
system. As replacement of the stimulator or new implantation of a DBS device is
a surgery that will need to be performed anyhow, there is no additional
surgical risk. In addition to the possibilities for recording brain activity,
the experimental stimulators have exactly the same functional performance as
the regular stimulators, so that there will be no loss of therapeutic effect
for the patients. There are no risks associated with EEG acquisition and the
burden can be considered minimal. The treatment itself is not a point of
investigation in this study. We classify this study as having a low chance of
possible risks and a low degree of harm, leading to a moderate risk to
patients, since a DBS system is used outside of the intended use.
The main burden for the patient consists of a 15-20% shorter (1.5-2 months)
shorter interval between two stimulator replacement surgeries, as the
experimental stimulator has a shorter lifetime than a regular stimulator due to
the recordings. Additional burden will be the periods of symptom provocation
they will have to endure when the stimulators are turned off and during
provocation tasks, and the time and effort they are asked to invest in the
study visits and in recording their symptoms and daily activities at home,
according to the study protocol.
Meibergdreef 5
Amsterdam 1105AZ
NL
Meibergdreef 5
Amsterdam 1105AZ
NL
Listed location countries
Age
Inclusion criteria
Subject has provided informed consent.
Primary diagnosis of OCD with DBS-implantation performed in the AMC in the
previous years.
Primary diagnosis of OCD and indicated for DBS-implantation in the AMC.
DBS-treatment responsiveness, defined as an improvement in Y-BOCS of >35% at
last follow-up compared to pre-surgical baseline
Exclusion criteria
Subject is unwilling or unable to comply with all study-required follow-up
evaluations.
Alcohol or substance abuse during last 6 months
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL52782.018.15 |
Other | NL7486 |